Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on equity (ROE) is -506.63% as of the fiscal period ended Tuesday, June 30, 2026.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation.
Limited quarterly history available
ROE needs at least three reported quarters before a meaningful chart is shown.
RETURN ON EQUITY (ROE)
-506.63%
RETURN ON EQUITY (ROE) AVG TTM
N/A
RETURN ON EQUITY (ROE) AVG 3Y
N/A
RETURN ON EQUITY (ROE) AVG 5Y
N/A
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-37.66%
median of 436 covered companies
CURRENT VS SECTOR MEDIAN
-1245.28%
vs the sector median at left
Caring Brands, Inc.
Market Cap
$10.27M
Return on Equity (ROE)
-506.63%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.07M
Return on Equity (ROE)
-317.20%
TTM Avg
510.39%
3Y Avg
317.15%
5Y Avg
239.40%
Market Cap
$10.74M
Return on Equity (ROE)
-477.54%
TTM Avg
-207.60%
3Y Avg
64.51%
5Y Avg
-22.91%
Market Cap
$9.79M
Return on Equity (ROE)
-440.15%
TTM Avg
-145.56%
3Y Avg
-96.97%
5Y Avg
-42.16%
Market Cap
$10.86M
Return on Equity (ROE)
-214.92%
TTM Avg
-46.13%
3Y Avg
-156.76%
5Y Avg
-652.77%
Market Cap
$9.63M
Return on Equity (ROE)
-2248.48%
TTM Avg
-970.82%
3Y Avg
-532.13%
5Y Avg
-347.08%
Market Cap
$11.01M
Return on Equity (ROE)
-85.82%
TTM Avg
-222.53%
3Y Avg
-140.00%
5Y Avg
-73.12%
Market Cap
$9.42M
Return on Equity (ROE)
N/A
TTM Avg
-2138.11%
3Y Avg
-1780.63%
5Y Avg
-1152.40%
Market Cap
$11.21M
Return on Equity (ROE)
-65.18%
TTM Avg
-26.62%
3Y Avg
-94.28%
5Y Avg
-90.35%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caring Brands, Inc. (CABR) | $10.27M | -506.63% | N/A | N/A | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $10.07M | -317.20% | 510.39% | 317.15% | 239.40% |
| Cerenome, Inc. (CNSY)vs › | $10.74M | -477.54% | -207.60% | 64.51% | -22.91% |
| Ainos, Inc. (AIMD)vs › | $9.79M | -440.15% | -145.56% | -96.97% | -42.16% |
| BioVie Inc. (BIVI)vs › | $10.86M | -214.92% | -46.13% | -156.76% | -652.77% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.63M | -2248.48% | -970.82% | -532.13% | -347.08% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.01M | -85.82% | -222.53% | -140.00% | -73.12% |
| HeartSciences Inc. (HSCS)vs › | $9.42M | N/A | -2138.11% | -1780.63% | -1152.40% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.21M | -65.18% | -26.62% | -94.28% | -90.35% |
| Biofrontera Inc. (BFRI)vs › | $11.41M | -106.87% | -250.57% | -230.96% | -240.83% |
ROE
-506.6%
ROA
-404.6%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -506.63% |
